Literature DB >> 27903526

Hepcidin upregulation by inflammation is independent of Smad1/5/8 signaling by activin B.

Céline Besson-Fournier1, Aurélie Gineste1, Chloé Latour1, Ophélie Gourbeyre1, Delphine Meynard1, Patricia Martin1,2, Eric Oswald1,2, Hélène Coppin1, Marie-Paule Roth1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27903526     DOI： 10.1182/blood-2016-10-748541

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  16 in total

1.  A Human Proteome Array Approach to Identifying Key Host Proteins Targeted by Toxoplasma Kinase ROP18.

Authors:  Zhaoshou Yang; Yongheng Hou; Taofang Hao; Hee-Sool Rho; Jun Wan; Yizhao Luan; Xin Gao; Jianping Yao; Aihua Pan; Zhi Xie; Jiang Qian; Wanqin Liao; Heng Zhu; Xingwang Zhou
Journal:  Mol Cell Proteomics       Date:  2017-01-13       Impact factor: 5.911

Review 2.  Liver iron sensing and body iron homeostasis.

Authors:  Chia-Yu Wang; Jodie L Babitt
Journal:  Blood       Date:  2018-11-06       Impact factor: 22.113

Review 3.  Iron and inflammation - the gut reaction.

Authors:  Smriti Verma; Bobby J Cherayil
Journal:  Metallomics       Date:  2017-02-22       Impact factor: 4.526

4.  Ablation of Hepatocyte Smad1, Smad5, and Smad8 Causes Severe Tissue Iron Loading and Liver Fibrosis in Mice.

Authors:  Chia-Yu Wang; Xia Xiao; Abraham Bayer; Yang Xu; Som Dev; Susanna Canali; Anil V Nair; Ricard Masia; Jodie L Babitt
Journal:  Hepatology       Date:  2019-08-13       Impact factor: 17.425

5.  The immunophilin FKBP12 inhibits hepcidin expression by binding the BMP type I receptor ALK2 in hepatocytes.

Authors:  Silvia Colucci; Alessia Pagani; Mariateresa Pettinato; Irene Artuso; Antonella Nai; Clara Camaschella; Laura Silvestri
Journal:  Blood       Date:  2017-09-01       Impact factor: 22.113

6.  Momelotinib inhibits ACVR1/ALK2, decreases hepcidin production, and ameliorates anemia of chronic disease in rodents.

Authors:  Malte Asshoff; Verena Petzer; Matthew R Warr; David Haschka; Piotr Tymoszuk; Egon Demetz; Markus Seifert; Wilfried Posch; Manfred Nairz; Pat Maciejewski; Peter Fowles; Christopher J Burns; Gregg Smith; Kay-Uwe Wagner; Guenter Weiss; J Andrew Whitney; Igor Theurl
Journal:  Blood       Date:  2017-02-10       Impact factor: 22.113

Review 7.  Balance of cardiac and systemic hepcidin and its role in heart physiology and pathology.

Authors:  Driton Vela
Journal:  Lab Invest       Date:  2017-10-23       Impact factor: 5.662

Review 8.  Bone morphogenic proteins in iron homeostasis.

Authors:  Xia Xiao; Víctor M Alfaro-Magallanes; Jodie L Babitt
Journal:  Bone       Date:  2020-06-23       Impact factor: 4.398

Review 9.  Physiological and pathophysiological mechanisms of hepcidin regulation: clinical implications for iron disorders.

Authors:  Yang Xu; Víctor M Alfaro-Magallanes; Jodie L Babitt
Journal:  Br J Haematol       Date:  2020-12-14       Impact factor: 8.615

10.  Role of Activins in Hepcidin Regulation during Malaria.

Authors:  Natasha Spottiswoode; Andrew E Armitage; Andrew R Williams; Alex J Fyfe; Sumi Biswas; Susanne H Hodgson; David Llewellyn; Prateek Choudhary; Simon J Draper; Patrick E Duffy; Hal Drakesmith
Journal:  Infect Immun       Date:  2017-11-17       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.